Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Krystal Biotech stock
Learn how to easily invest in Krystal Biotech stock.
Krystal Biotech Inc is a biotechnology business based in the US. Krystal Biotech shares (KRYS) are listed on the NASDAQ and all prices are listed in US Dollars. Krystal Biotech employs 75 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Krystal Biotech
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – KRYS – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Krystal Biotech stock price (NASDAQ: KRYS)Use our graph to track the performance of KRYS stocks over time.
Krystal Biotech shares at a glance
|Latest market close||$57.06|
|52-week range||$38.86 - $102.99|
|50-day moving average||$63.30|
|200-day moving average||$62.06|
|Wall St. target price||$126.86|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-2.72|
Buy Krystal Biotech shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Krystal Biotech stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Krystal Biotech price performance over time
|1 week (2022-01-18)||-3.94%|
|1 month (2021-12-22)||N/A|
|3 months (2021-10-26)||4.81%|
|6 months (2021-07-26)||-0.56%|
|1 year (2021-01-26)||-19.83%|
|2 years (2020-01-24)||1.86%|
|3 years (2019-01-25)||146.27%|
|5 years (2017-01-22)||N/A|
Krystal Biotech financials
|Gross profit TTM||$0|
|Return on assets TTM||-9.31%|
|Return on equity TTM||-16.38%|
|Market capitalisation||$1.4 billion|
TTM: trailing 12 months
Krystal Biotech share dividends
We're not expecting Krystal Biotech to pay a dividend over the next 12 months.
Krystal Biotech share price volatility
Over the last 12 months, Krystal Biotech's shares have ranged in value from as little as $38.856 up to $102.99. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Krystal Biotech's is 0.9062. This would suggest that Krystal Biotech's shares are less volatile than average (for this exchange).
Krystal Biotech overview
Krystal Biotech, Inc. , a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing KB105 that is in Phase I/II clinical study for treating patients with deficient autosomal recessive congenital ichthyosis; KB301, which is in Phase I/II clinical stage for treating wrinkles and acne scars; KB407 that is in preclinical stage for cystic fibrosis; and KB104, which is in preclinical stage for netherton syndrome. Its discovery stage product candidates include KB5xx for treating chronic skin diseases, KB3xx to treat aesthetic skin conditions, and KB3xx for other rare lung disease. Krystal Biotech, Inc. was founded in 2015 and is headquartered in Pittsburgh, Pennsylvania.
Krystal Biotech in the news
Netflix shares fall near pre-pandemic level as investors fear slowing subscriber growth, competition
Stocks making the biggest moves midday: Netflix, Kohl's, Wynn Resorts, General Motors and more
RBC upgrades Comcast to outperform on subscriber growth
Frequently asked questionsWhat percentage of Krystal Biotech is owned by insiders or institutions?
Currently 21.927% of Krystal Biotech shares are held by insiders and 70.33% by institutions. How many people work for Krystal Biotech?
Latest data suggests 75 work at Krystal Biotech. When does the fiscal year end for Krystal Biotech?
Krystal Biotech's fiscal year ends in December. Where is Krystal Biotech based?
Krystal Biotech's address is: 2100 Wharton Street, Pittsburgh, PA, United States, 15203 What is Krystal Biotech's ISIN number?
Krystal Biotech's international securities identification number is: US5011471027 What is Krystal Biotech's CUSIP number?
Krystal Biotech's Committee on Uniform Securities Identification Procedures number is: 501147102
More guides on Finder
Melania Trump has an NFT — what to know before you buy
Melania Trump launched an NFT platform — you can buy an image of her eyes.
Vigorus (VIS) price prediction
Read our expert analysis on Vigorus and how the token will perform in the future.
Dogecoin jumps 10% on word you can use it to buy Tesla merch
While there are no known plans to expand the acceptance of Doge to its cars, customers can already buy a Tesla with Bitcoin.
Thursday’s top U.S. stocks: Taiwan Semiconductor Manufacturing Company Ltd. (TSM ↑8.4%), Lam Research Corporation (LRCX ↑6.1%)
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Monie savings review
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
Covid test stocks
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Is Berkshire Hathaway the next $1 trillion stock?
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Tesla roars into 2022 after December drop
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.
How to buy Affinia Therapeutics (AFTX) stock when it goes public
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
How to buy Austin Gold (AUST) stock when it goes public
Everything we know about the Austin Gold IPO, plus information on how to buy in.
Ask an Expert